Biological Psychiatry 1999: Vol 46 Index

28 Pages·1999·10.8 MB·English

Author Index to Volume 46
Aardal-Eriksson E, Eriksson TE, Holm Alvarez E. See Figueras G Bahro M. See Sunderland T
A-C, Lundin T. Salivary cortisol Ambrogi F. See Marazziti D Bakish D. See Du L
and serum prolactin in relation to Andersen SW. See Tollefson GD Ballenger JC. Current treatments of the
stress rating scales in a group of Anderson JW. See Bresnaham SM anxiety disorders in adults, 1579
rescue workers, 850 Andreasen NC. See Corson PW Barch DM. See Braver TS
Aarnoudse CC. See Althaus M Andreasen NC. See Nopoulos PC Barry RJ. See Bresnaham SM
Abi-Dargham A. See Laruelle M Andreasen NC, Nopoulos PC, O’ Leary Barry RJ. See Manor BR
Adams JB. See Pande AC DS, Miller DD, Wassink T, Flaum Bar-Sever M. See Apter A
Adler DM. See Friedman JI M. Defining the phenotype of Bartko JJ. See Wyatt RJ
Adler LE. See Ross RG schizophrenia: cognitive dysmetria Bassett AS. See Chow EWC
Adler LE, Freedman R, Ross RG, Olincy and its neural mechanisms, 908 Bassett AS, Chow EWC. 22q11 deletion
A, Waldo MC. Elementary Angelini C. See Perini GI syndrome: a genetic subtype of
phenotypes in the neurobiological Anisman H, Ravindran AV, Griffiths J, schizophrenia, 882
and genetic study of schizophrenia, Merali Z. Interleukin-1 production Bauer LO, Hesselbrock VM. P300
8 in dysthymia before and after
dec e:. ents in teenagers with
Aghajanian GK. See Nestler EJ pharmacotherapy, 1649 conduct problems: implications for
Agren H. See Degl’Innocenti A Annoh N. See Yamasa S substance abuse risk and brain
Akil H. See Lépez JF Apter A, Laufer N, Bar-Sever M, Har- development, 263
Alberti A, Pirrone P, Elia M, Waring RH, Even D, Ofek H, Weizman A.
Beal M. See Ford JM
Romano C. Sulphation deficit in Serum cholesterol, suicidal
Bedwell J. See Giedd JN
“low-functioning” autistic children: tendencies, impulsivity, aggression,
Beersma DGM. See Meesters Y
a pilot study, 420 and depression in adolescent
Begleiter H. See Rodriguez Holguin S
Alila-Johansson A. See Haténen T psychiatric inpatients, 532
Beiser M. See Curtis CE
Allen J. See Moreno FA Arango C. See Carpenter WT Jr
Belger A. See Hoffman RE
Allen NB, Trinder J, Brennan C. Arango V. See Underwood MD
Benes FM. Evidence for altered
Affective startle modulation in Arborelius L. See Linnér L
trisynaptic circuitry in
clinical depression: preliminary Arciniegas D. See Reite M
schizophrenic hippocampus, 589
findings, 542 Arndt S. See Corson PW
Benson BE. See Ketter TA
Allilaire J-F. See Leboyer M. Arndt S. Landmark analysis of corpus
Benson BE. See Kimbrell TA
Alpert JE, Fava M, Uebelacker LA, callosum shape in schizophrenia,
Benson M. See Singer HS
Nierenberg AA, Pava JA, 1713-corr (response)
Berent S. See Starkman MN
Worthington JJ III, Rosenbaum JF. Arnsten AFT. See Birnbaum S
Berg PH. See Breier A
Patterns of Axis I comorbidity in Arnsten AFT. See Mao Z-M
Bergstr6m M. See Lindstrém LH
early-onset versus late-onset major Arnsten AFT. See Southwick SM
Berman A. See Malaspina D
depressive disorder, 202 Artigas F. See Figueras G
Berman RM. See D’Souza DC
Alpert NM. See Dougherty DD Aschauer H. See Feucht M
Berman RM. See Hoffman RE
Alreja M. See Nestler EJ Ashman SB. See Leibenluft E
Berry SA. See Schulz SC
Altemus M. See Gendall KA Aston-Jones G, Rajkowski J, Cohen J.
Bertilsson L. See Linnér L
Althaus M, Mulder LJM, Mulder G, Role of locus coeruleus in attention
Biederman J, Spencer T.
Aarnoudse CC, Minderaa RB. and behavioral flexibility, 1309
ssttention-deficit/hyperactivity
Cardiac adaptivity to attention- Auerbach J. See Birnbaum S
disorder (ADHD) as a
demanding tasks in children with a Avenevoli S. See Merikangas KR
noradrenergic disorder, 1234
pervasive developmental disorder
not otherwise specified (PDD- Bachevalier J, Alvarado MC, Malkova L. Binder EB. See Kinkead B
NOS), 799 Memory and socioemotional Birnbaum S, Gobeske KT, Auerbach J,
behavior in monkeys after Taylor JR, Arnsten AFT. A role for
Altshuler L. See van Gorp WG
hippocampal damage incurred in norepinephrine in stress-induced
Alvarado MC. See Bachevalier J
infancy or in adulthood, 329 cognitive deficits: a-1-adrenoceptor
Backman L. See Degl’ Innocenti A mediation in the prefrontal cortex,
Abbreviations:
Bahramali H. See Manor BR 1266
ed, editorial
corr, correspondence Bahro M. See Dukoff R Blennow K. See Landén M
© 1999 Society of Biological Psychiatry 0006-3223/99/$20.00
PII S0006-3223(99)00288-7
Author Index to Volume 46 BIOL PSYCHIATRY 1719
1999:46:1718-1727
Blumenthal J. See Giedd JN Carpenter WT Jr, Arango C, Buchanan Cohen JD. See Aston-Jones G.
Bouhuys AL. See Meesters Y RW, Kirkpatrick B. Deficit Cohen JD. See Braver TS
Boutros NN. See Hoffman RE psychopathology and a paradigm Cohen RM. See Tariot PN
Bowden CL, Calabrese JR, Cookson J, shift in schizophrenia research, 352 Coleman AE. See Jacobs AR
Monaghan E. The efficacy of Carpenter WT Jr, Zito JM, Volavka J. Coleman EA. See Light GA
lamotrigine in rapid cycling and Dopamine, receptor occupancy and Compagnon N. See Ross RG
non-rapid cycling patients with the action of clozapine: does it Conley RR, Tamminga CA, Kelly DL,
bipolar disorder, 1711-corr make a difference to add a Richardson CM. Treatment-resistant
(response) neuroleptic?, 147-corr (response) schizophrenic patients respond to
Braff DL. See Davis KL Cassano GB. See Marazziti D clozapine after olanzapine non-
Braff DL. See Light GA Castellanos FX. See Giedd JN response, 73
Braff DL. See Paulus MP Cathcart S. See Sachdev P
Connolly J. See Hill SY
Braun HA. See Huber MT Catts SV. See Levitan C
Conway A. See Dukoff R
Braver TS, Barch DM, Cohen JD. Cavallini MC, Perna G, Caldirola D,
Cookson J. See Bowden CL
Cognition and control in Bellodi L. A segregation study of
Cooper SJ. See Johnston TG
schizophrenia: a computational panic disorder in families of panic
Coplan JD. See Sullivan GM
model of dopamine and prefrontal patients responsive to the 35% CO2
Corson PW, Nopoulos PC, Andreasen
function, 312 challenge, 815
NC, Heckel D, Arndt S. Caudate
Breier A, Berg PH. The psychosis of Caviness VS. See Seidman LJ
size in first-episode neuroleptic-
schizophrenia: prevalence, response Ceilley JW. See Nopoulos PC
naive schizophrenic patients
to atypical antipsychotics, and Champagne F. See Francis DD
measured using an artificial neural
prediction of outcome, 361 Charney DS. See Delgado PL
network, 712
Breier JI. See Leonard CM Charney DS. See D’Souza DC
Costa MM, Reus VI, Wolkowitz OM,
Bremner JD. See Southwick SM Charney DS. See Duman RS
Manfredi F, Lieberman M. Estrogen
Brennan C. See Allen NB Charney DS. See Hoffman RE
replacement therapy and cognitive
Bresnahan SM, Anderson JW, Barry RJ. Charney DS. See Southwick SM
decline in memory-impaired
Age-related changes in quantitative Charney DS, Innis RB, Nestler EJ. New
postmenopausal women, 182
EEG in attention-deficit/ Requirements for manuscripts
Cowen PJ. See Franklin M
hyperactivity disorder, 1690 submitted to Biological Psychiatry:
Cox C. See Tariot PN
Bromet EJ, Fennig S. Epidemiology and informed consent and protection of
Curtis CE, Iacono WG, Beiser M.
natural history of schizophrenia, subjects, 1007-ed
Relationship between nailfold
871 Charney DS, Innis RB, Nestler EJ, Davis
plexus visibility and clinical,
Brugge K, Nichols S, Saitoh T, Trauner KL, Nemeroff CB, Weinberger DR.
neuropsychological, and brain
D. Correlations of glutathione Increasing public trust and
structural measures in
peroxidase activity with memory confidence in psychiatric research,
schizophrenia, 102
impairment in adults with Down l-ed
Cvetkovic N. See Feucht M
syndrome, 1682 Chen G. See Manji HK
Buchanan RW. See Carpenter WT Jr Cherek DR, Lane SD. Laboratory and
Danielson AL. See Ketter TA
Burt T. See Nierenberg AA psychometric measurements of
Danielson AL. See Kimbrell TA
Bustillo J. See Lauriello J impulsivity among violent and
Davidsson P. See Landén M
Byne W. See Friedman JI nonviolent female parolees, 273
Davis CL. See Hough C
Chi J. See Franklin M
Davis KL. See Charney DS
Calabrese JR. See Bowden CL Chistyakov A. See Klein E
Davis KL. See Friedman JI
Caldji C. See Francis DD Chorlian DB. See Rodriguez Holguin S
Davis KL, Braff DL, Weinberger DR.
Camlin KL. See Schulz SC Chow EWC. See Bassett AS
Campling G. See Franklin M Chow EWC, Mikulis DJ, Zipursky RB, Protecting research subjects and
Carlsson A, Waters N., Carlsson ML. Scutt LE, Weksberg R, Bassett AS. psychiatric research: we can do
Neurotransmitter interactions in Qualitative MRI findings in adults both, 727-ed
schizophrenia—therapeutic with 22q11 deletion syndrome and DeBose CAQ. See Leonard CM
implications, 1388 schizophrenia, 1436 Dechent P, Pouwels PJW, Frahm J.
Carlsson ML. See Carlsson A Chuang D-M. See Hough C Neither short-term nor long-term
Caron MG. See Gainetdinov RR Clarke AS, Ebert MH, Schmidt DE, administration of oral choline alters
Caron MG. See Wang Y-M McKinney WT, Kraemer GW. metabolite concentrations in human
Carpenter LL. See Longhurst JG Biogenic amine activity in response brain, 406
Carpenter WT Jr. The schizophrenia to fluoxetine and desipramine in Degl’Innocenti A, Agren H, Zachrisson
ketamine challenge study debate, differentially reared rhesus O, Backman L. The influence of
1081 monkeys, 221 prolactin response to d-fenfluramine
1720 BIOL PSYCHIATRY Author Index to Volume 46
1999:46:1718-—1727
on executive functioning in major allele in serotonin transporter gene the short-term response to
depression, 512 is increased in depressed suicide paroxetine in major depression, 518
Delgado PL. See Moreno FA victims, 196 Findling RL. See Friedman L
Delgado PL, Miller HL, Salomon RM, Duan SX. See von Moltke LL Fischman AJ. See Dougherty DD
Licinio J, Krystal JH, Moreno FA, Dukoff R. See Sunderland T Flaum M. See Andreasen NC
Heninger GR, Charney DS. Dukoff R, Wilkinson CW, Lasser R, Friz Fletcher DJ. See Neylan TC
Tryptophan-depletion challenge in J, Conway A, Bahro M, Peskind Fogelman SM. See von Moltke LL
depressed patients treated with ER, Sunderland T. Physostigmine Foote SL. Development and vulnerability:
desipramine or fluoxetine: challenge before and after chronic new perspectives for anxiety
implications for the role of cholinergic blockade in elderly disorders, 1457-ed
serotonin in the mechanism of volunteers, 189 Ford JM, Mathalon DH, Marsh L,
antidepressant action, 212 Duman RS, Charney DS. New vistas for Faustman WO, Harris D, Hoff AL,
DeMet EM, Sokolski KN. Sodium an old neurotransmitter, 1121-ed Beal M, Pfefferbaum A. P300
valproate increases pupillary Duman RS, Malberg J, Thome J. Neural amplitude is related to clinical state
responsiveness to a cholinergic plasticity to stress and in severely and moderately ill
agonist in responders with mania, antidepressant treatment, 1181 patients with schizophrenia, 94
432 Dunn RT. See Kimbrell TA Frahm J. See Dechent P
Demeter E. See Du L Francis DD, Caldji C, Champagne F,
Demirkol A, Erdem H, Inan L, Yigit A, Ebert MH. See Clarke AS Plotsky PM, Meaney MJ. The role
Giiney M. Bilateral globus pallidus Edelheit PB. See Jacobs AR of corticotropin-releasing factor—
lesions in a patient with Tourette Eilson WH. See McEvoy JP norpinephrine systems in mediating
syndrome and related disorders, 863 Elbein AD. See Kyosseva SV the effects of early experience on
DeQuardo JR. Landmark analysis of Elia M. See Abderti A the development of behavioral and
corpus callosum shape in Ellis SP. See Underwood MD endocrine responses to stress, 1153
schizophrenia, 1712-corr Elpern S. See Roca CA Frangou S. See Stefanis N
Deuschle M. See Schmider J Epperson CN. See Longhurst JG Frank E. See Drevets WC
Deutz NEP. See Klaasen T Erdem H. See Demirkol A Franklin M, Chi J, McGavin C, Hockney
Di Chiara G, Loddo P, Tanda G. Eriksson TE. See Aardal-Eriksson E R, Reed A, Campling G, Whale
Reciprocal changes in prefrontal Ermani M. See Perini GI RWR, Cowen PJ. Neuroendocrine
and limbic dopamine Esser P. See Malaspina D evidence for dopaminergic actions
responsiveness to aversive and of hypericum extract (LI 160) in
rewarding stimuli after chronic mild Faludi G. See Du L healthy volunteers, 581
stress: implications for the Faraone SV. See Seidman LJ Freedman R. See Adler LE
psychobiology of depression, 1624 Faustman WO. See Ford JM Freedman R. See Ross RG
Dierker L. See Merikangas KR Fava M. See Alpert JE Freedman R. See Stevens KE
Dilley GE. See Zhu M-Y Fein G. See Neylan TC Freedman R. Schizophrenia as a neuronal
Don-Tufeled O. See Soreni N Feinsod M. See Klein E illness, 587-ed
Dougherty DD, Shin LM, Alpert NM, Feldman-Naim S. See Leibenluft E Freudenreich O. See McEvoy JP
Pitman RK, Orr SP, Lasko M, Fennig S. See Bromet EJ Friedman JI, Adler DN, Davis KL. The
Macklin ML, Fischman AJ, Rauch Fernandez T. See Giedd JN role of norepinephrine in the
SL. Anger in healthy men: a PET Ferruzza E. See Perini GI pathophysiology of cognitive
study using script-driven imagery, Ferry B, Roozendaal B, McGaugh JL. disorders: potential applications to
466 Role of norepinephrine in mediating the treatment of cognitive
Drancoli J. See Schmider J stress hormone regulation of long- dysfunction in schizophrenia and
Drevets WC, Frank E, Price JC, Kupfer term memory storage: a critical Alzheimer’s disease, 1243
DJ, Holt D, Greer PJ, Huang Y, involvement of the amygdala, 1140 Friedman JI, Harvey PD, Kemether E,
Gautier C, Mathis C. PET imaging Feucht M, Fuchs K, Pichlbauer E, Hornik Byne W, Davis KL. Cognitive and
of serotonin 1A receptor binding in K, Scharfetter J, Goessler R, functional changes with aging in
depression, 1375 Fiireder T, Cvetkovic N, Sieghart schizophrenia, 921
D’Souza DC, Berman RM, Krystal JH, W, Kasper S, Aschauer H. Possible Friedman L, Findling RL, Kenny JT,
Charney DS. Symptom provocation association between childhood Swales TP, Stuve TA, Jesberger
studies in psychiatric disorders: absence epilepsy and the gene JA, Lewin JS, Schulz SC. An MRI
scientific value, risks, and future, encoding GABRB3, 997 study of adolescent patients with
1060 Figueras G, Pérez V, San Martino O, either schizophrenia or bipolar
Du L, Faludi G, Palkovits M, Demeter E, Alvarez E, Grupo de Trastornos disorder as compared to healthy
Bakish D, Lapierre YD, Sétonyi P, Afectivos, Artigas F. Pretreatment control subjects, 78, 585
Hrdina PD. Frequency of long platelet 5-HT concentration predicts Friz J. See Dukoff R
ag
Author Index to Volume 46 BIOL PSYCHIATRY 1721
1999:46:1718-1727
Frye MA. See Ketter TA Gorman JM. See Printz DJ pathophysiology of anxiety and
Frye MA. See Kimbrell TA Gorman JM. See Sullivan GM affective disorders, 1509
Fuchs K. See Feucht M Gotowiec A. See Hudson C Hell D. See Park S
Fiireder T. See Feucht M Gottfries C-G. See Landén M Heninger GR. See Delgado PL
Furman V. See Malaspina D Gould E, Tanapat P. Stress and Heninger GR. See Moreno FA
hippocampal neurogenesis, 1472 Henter ID. See Wyatt RJ
Gailis EA. See Nopoulos PC Grace AA. See Moore H Heron D-C. See Leonard CM
Gainetdinov RR. See Wang Y-M Granda BW. See von Moltke LL Herrera-Estrella M. See Salin-Pascual RJ
Gainetdinov RR, Jones SR, Caron MG. Grassi JM. See von Moltke LL Herscovitch P. See Ketter TA
Functional hyperdopaminergia in Greenberg BD. See Kimbrell TA Herscovitch P. See Kimbrell TA
dopamine transporter knock-out Greenblatt DJ. See von Moltke LL Herzog AG. See Jacobs AR
mice, 303 Greer PJ. See Drevets WC Hesselbrock VM. See Bauer LO
Galasko D. See Sunderland T Greiner M. See Pande AC Heuser I. See Schmider J
Galicia-Polo L. See Salin-Pascual RJ Grenfeldt B. See Landén M High JR. See Southwick SM
Gautier C. See Drevets WC Griffin WST. See Kyosseva SV Higley JD. See Lindell SG
Gautier ER. See Leonard CM Griffiths J. See Anisman H Hill H. See Weisbrod M
Gavish M. See Soreni N Grillon C. See Merikangas KR Hill SY, Locke J, Steinhauer SR.
Gebarski SS. See Starkman MN Grupo de Trastornos Afectivos. See Absence of visual and auditory
Gefvert O. See Lindstr6m LH Figueras G P300 reduction in nondepressed
Gelenberg AJ. See Moreno FA Giiney M. See Demirkol A male and female alcoholics, 982
Gemignani A. See Marazziti D Hill SY, Shen S, Locke J, Steinhauer SR,
Gemma A. See Perini GI Haas GL. See Sweeney JA Konicky C, Lowers L, Connolly J.
Gendall KA, Kaye WH, Altemus M, Hagberg G. See Lindstrém LH Developmental delay in P300
McConaha CW, La Via MC. Hall LL. Medication discontinuation and production in children at high risk
Leptin, neuropeptide Y, and peptide symptom provocation in research: a for developing alcohol-related ,
YY in long-term recovered eating consumer and family perspective, disorders, 970 ae
disorder patients, 292 1017 Hoagwood K. See Vitiello B
Gennarelli M. See Perini GI Hallett JJ. See Singer HS Hockney R. See Franklin M
George MS. See Ketter TA Hamburger SD. See Giedd JN Hoff AL. See Ford JM
George MS. See Kimbrell TA Hamer RM, Simpson PM. The efficacy of Hoffman RE, Boutros NN, Berman RM,
Geyer MA. See Light GA lamotrigine in rapid cycling and Roessler E, Belger A, Krystal JH,
Giedd JN, Jeffries NO, Blumenthal J, non-rapid cycling patients with Charney DS. Transcranial magnetic
Castellanos FX, Vaituzis AC, bipolar disorder, 1711-corr stimulation of left temporoparietal
Fernandez T, Hamburger SD, Liu Hansen BH. See Singer HS cortex in three patients reporting
H, Nelson J, Bedwell J, Tran L, Hanstock CC. See Silverstone PH hallucinated “voices,” 130
Lenane M, Nicolson R, Rapoport Harano M. See Yamasa S Holm A-C. See Aardal-Eriksson E
JL. Childhood-onset schizophrenia: Hardan A, Birmaher B, Williamson DE, Holmes C. See Raskind MA
progressive brain changes during Dahl RE, Ambrosini P, Rabinovich Holsboer F. See Steckler T
adolescence, 892 H, Ryan ND. Prolactin secretion in Holsboer F. See Strdhle A
Gil R. See Laruelle M depressed children, 506 Holt D. See Drevets WC
Ginsburg GS. See Labellarte MJ Har-Even D. See Apter A Honig A. See Klaasen T
Giordani B. See Starkman MN Harmatz JS. See von Moltke LL Hornik K. See Feucht M
Giuliano JD. See Singer HS Harris D. See Ford JM Hough C, Lu S-J, Davis CL, Chuang
Gobeske KT. See Birnbaum S Harris JG. See Ross RG D-M, Post RM. Elevated basal and
Goessler R. See Feucht M Harris MJ. See Jeste DV thapsigargin-stimulated intracellular
Goetz R. See Printz DJ Hartvig P. See Lindstr6m LH calcium of platelets and
Goldman D. See Lappalainen J Harvey PD. See Friedman JI lymphocytes from bipolar affective
Goldman-Rakic PS. See Selemon LD Hashimoto T. See Lin X-H disorder patients measured by a
Goldman-Rakic PS. The physiological Haténen T, Alila-Johansson A, Mustanoja fluorometric microassay, 247
approach: functional architecture of S, Laakso M-L. Suppression of Howson AL. See Knott VJ
working memory and disordered melatonin by 2000-lux light in Hrdina PD. See Du L
cognition in schizophrenia, 650 humans with closed eyelids, 827 Huang Y. See Drevets WC
Goldstein DS. See Raskind MA Haycock JW. See Zhu M-Y Huber MT, Braun HA, Krieg JC.
Goldstein JM. See Seidman LJ Heckel D. See Corson PW Consequences of deterministic and
Goodman JM. See Seidman LJ Heim C, Nemeroff CB. The impact of random dynamics for the course of
Gordon E. See Manor BR early adverse experiences on brain affective disorders, 256
Gorman JM. See Malaspina D systems involved in the Hudson C, Gotowiec A, Seeman M,
1722 BIOL PSYCHIATRY Author Index to Volume 46
1999:46:1718-1727
Warsh J, Ross BM. Clinical Kem WR. See Stevens KE transcranial magnetic stimulation in
subtyping reveals significant Kemether E. See Friedman JI schizophrenia: a double-blind sham-
differences in calcium-dependent Kemner C, van der Gaag RJ, Verbaten controlled pilot study, 1451
phospholipase A, activity in M, van Engeland H. ERP Klimek V. See Zhu M-Y
schizophrenia, 401 differences among subtypes of Knott VJ, Howson AL, Perugini M,
Hughes HB. See Zubenko GS pervasive developmental disorders, Ravindran AV, Young SN. The
Hyman SE. See Shore D 781 effect of acute tryptophan depletion
Kennedy D. See Seidman LJ and fenfluramine on quantitative
Iacono WG. See Curtis CE Kenny JT. See Friedman L EEG and mood in healthy male
Inan L. See Demirkol A Kent JM. See Sullivan GM subjects, 229
Innis R. See Laruelle M Keshavan MS. See Sweeney JA Kolsky Y. See Klein E
Innis RB. See Charney DS Ketter TA, Kimbrell TA, George MS, Konicky C. See Hill SY
Innis RB. See Soares JC Willis MW, Benson BE, Danielson Koob GF. Corticotropin-releasing factor,
Inoue S. See Izumoto Y A, Frye MA, Herscovitch P, Post norepinephrine, and stress, 1167
Izumoto Y, Inoue S, Yasuda N. RM. Baseline cerebral
Koren D. See Klein E
Schizophrenia and the influenza hypermetabolism associated with
Kraemer GW. See Clarke AS
epidemics of 1957 in Japan, 119 carbamazepine response, and
Kremen WS. See Seidman LJ
hypometabolism with nimodipine
Krieg JC. See Huber MT
Jacobs AR, Edelheit PB, Coleman AE, response in mood disorders, 1364
Krolewski J. See Printz DJ
Herzog AG. Late-onset congenital Ketter TA. See Kimbrell TA
Krystal JH. See Delgado PL
adrenal hyperplasia: a treatable Khaibulina AA. See Underwood MD
Krystal JH. See D’Souza DC
cause of anxiety, 856 Kidd KK. See Kang AM
Krystal JH. See Hoffman RE
Jeffries NO. See Giedd JN Kidd KK. See Palmatier MA
Kuldau JM. See Leonard CM
Jensen PS. See Vitiello B Kiessling LS. See Singer HS
Kupfer DJ. See Drevets WC
Jesberger JA. See Friedman L Kimbrell TA. See Ketter TA
Kyosseva SV, Elbein AD, Griffin WST,
Jesberger JA. See Schulz SC Kimbrell TA, George MS, Parekh PI,
Mrak RE, Lyon M, Karson CN.
Jeste DV, Palmer BW, Harris Ketter TA, Podell DM, Danielson
Mitogen-activated protein kinases in
MJ. Neuroleptic discontinuation in AL, Repella JD, Benson BE, Willis
schizophrenia, 689
clinical and research settings: MW, Herscovitch P, Post RM.
scientific issues and ethical Regional brain activity during
Laakso M-L. See Haténen T
dilemmas, 1050 transient self-induced anxiety and
Labellarte MJ, Ginsburg GS, Walkup JT,
Johnston TG, Kelly CB, Stevenson MR, anger in healthy adults, 454
Riddle MA. The treatment of
Cooper SJ. Plasma norepinephrine Kimbrell TA, Little JT, Dunn RT, Frye
anxiety disorders in children and
and prediction of outcome in major MA, Greenberg BD, Wassermann
adolescents, 1567
depressive disorder, 1253 EM, Repella JD, Danielson AL,
LaMantia A-S. Forebrain induction,
Jones SR. See Gainetdinov RR Willis MW, Benson BE, Speer AM,
retinoic acid, and vulnerability to
Osuch E, George MS, Post RM.
schizophrenia: insights from
Kagan J, Snidman N. Early childhood Frequency dependence of
molecular and genetic analysis in
predictors of adult anxiety antidepressant response to left
developing mice, 19
disorders, 1536 prefrontal repetitive transcranial
Landén M, Davidsson P, Gottfries C-G,
Kane JM. Pharmacologic treatment of magnetic stimulation (rTMS) as a
Grenfeldt B, Stridsberg M,
schizophrenia, 1396 function of baseline cerebral
Kang AM. See Palmatier MA glucose metabolism, 1603 Blennow K. Reduction of the small
Kang AM, Palmatier MA, Kidd KK. Kinkead B, Binder EB, Nemeroff CB. synaptic vesicle protein
Global variation of a 40-bp VNTR Does neurotensin mediate the synaptophysin but not the large
in the 3’-untranslated region of the effects of antipsychotic drugs?, 340 dense core chromogranins in the
dopamine transporter gene Kirkpatrick B. See Carpenter WT Jr left thalamus of subjects with
(SLC6A3), 151 Kitamura N. See Lin X-H schizophrenia, 1698
Karp L. See Soreni N Klaasen T, Riedel WJ, van Someren A, Lane A. See Waddington JL
Karson CN. See Kyosseva SV Deutz NEP, Honig A, van Praag Lane SD. See Cherek DR
Kasper S. See Feucht M HM. Mood effects of 24-hour Langstrém B. See Lindstré6m LH
Kaye WH. See Gendall KA tryptophan depletion in healthy Lapierre YD. See Du L
Kegeles L. See Laruelle M first-degree relatives of patients Lappalainen J, Long JC, Virkkunen M,
Keith SJ. See Lauriello J with affective disorders, 489 Ozaki N, Goldman D, Linnoila M.
Kellner M. See Stréhle A Klein E, Kolsky Y, Puyerovsky M, Koren HTR2C Cys23Ser polymorphism in
Kelly CB. See Johnston TG D, Chistyakov A, Feinsod M. Right relation to CSF monoamine
Kelly DL. See Conley RR prefrontal slow repetitive metabolite concentrations and
Author Index to Volume 46 BIOL PSYCHIATRY 1723
1999:46:1718-1727
DSM-III-R psychiatric diagnoses, and prefrontal cortical dysfunction tyrosine) in obsessive-compulsive
821 in schizophrenia, 616 disorder, 573
Larkin C. See Waddington JL Li B-M. See Mao Z-M Lépez JF, Akil H, Watson SJ. Neural
Laruelle M, Abi-Dargham A, Gil R, Licinio J. See Delgado PL circuits mediating stress, 1461
Kegeles L, Innis R. Increased Lidow MS. See Selemon LD Lowers L. See Hill SY
dopamine transmission in Lieberman JA. See Tamminga CA Loy R. See Tariot PN
schizophrenia: relationship to illness Lieberman JA. Is schizophrenia a Luber BM. See Light GA
phases, 56 neurodegenerative disorder? A Luna B. See Sweeney JA
Lasko M. See Dougherty DD clinical and neurobiological Lundberg T. See Lindstrém LH
Lasser R. See Dukoff R perspective, 729 Lundin T. See Aardal-Eriksson E
Lasser R. See Sunderland T Lieberman JA. Schizophrenia: comments Lydiard RB. See Pande AC
Latimer CR. See Manor BR on genes, development, risk factors, Lynch K. See Moss HB
Laufer N. See Apter A phenotype, and course, 869-ed Lyon M. See Kyosseva SV
Launay J-M. See Leboyer M. Lieberman M. See Costa MM
Lauriello J, Bustillo J, Keith SJ. A Light GA, Malaspina D, Geyer MA, Macklin ML. See Dougherty DD
Maeda K. See Lin X-H
critical review of research on Luber BM, Coleman EA, Sackeim
Makris N. See Seidman LJ
psychosocial treatment of HA, Braff DL. Amphetamine
Malaspina D. See Light GA
schizophrenia, 1409 disrupts P50 suppression in normal
Malaspina D. See Printz DJ
Laurino JP. See Singer HS subjects, 990
Malaspina D. Storer S, Furman V, Esser
Lavery EM. See Leonard CM Lignelli A. See Malaspina D
P, Printz D, Berman A, Lignelli A,
La Via MC. See Gendall KA Lin X-H, Kitamura N, Hashimoto T,
Gorman J, Van Heertum R. SPECT
Lawson C. See Potokar J Shirakawa O, Maeda K. Opposite
study of visual fixation in
Leboyer M, Quintin P, Manivet P, changes in phosphoinositide-
schizophrenia and comparison
Varoquaux O, Allilaire J-F, Launay specific phospholipase C
subjects, 89
J-M. Decreased serotonin immunoreactivity in the left
Malberg J. See Duman RS
transporter binding in unaffected prefrontal and superior temporal
Malkova L. See Bachevalier J
relatives of manic depressive cortex of patients with chronic
Manfredi F. See Costa MM
patients, 1703 schizophrenia, 1665
Manivet P. See Leboyer M.
Lehtimaki T. See Sunderland T Lindell SG, Suomi SJ, Shoaf S, Linnoila
Manji HK, Lenox RH. Protein kinase C
Leibenluft E, Ashman SB, Feldman-Naim M, Higley JD. Salivary prolactin as
signaling in the brain: molecular
S, Yonkers KA. Lack of a marker for central serotonin
transduction of mood stabilization
relationship between menstrual turnover, 568
in the treatment of manic-
cycle and mood in a sample of Lindstrém LH, Gefvert O, Hagberg G,
depressive illness, 1328
women with rapid cycling bipolar Lundberg T, Bergstrém M, Hartvig
Manji HK, Moore GJ, Chen G. Lithium
disorder, 577 P, Langstrém B. Increased
at 50: have the neuroprotective
Lemieux L. See van Elst LT dopamine synthesis rate in medial
effects of this unique cation been
Lenane M. See Giedd JN prefrontal cortex and striatum in
overlooked?, 929
Lenoci M. See Neylan TC schizophrenia indicated by L-
Mann JJ. See Sweeney JA
Lenox RH. See Manji HK (B-''C) DOPA and PET, 681
Mann JJ. See Underwood MD
Leonard CM, Kuldau JM, Breier JI, Linnér L, Arborelius L, Nomikos GG,
Manor BR, Gordon E, Williams LM,
Zuffante PA, Gautier ER, Heron Bertilsson L, Svensson TH. Locus
Rennie CJ, Bahramali H, Latimer
D-C, Lavery EM, Packing J, coeruleus neuronal activity and CR, Barry RJ, Meares RA. Eye
Williams SA, DeBose CA. noradrenaline availability in the movements reflect impaired face
Cumulative effect of anatomical frontal cortex of rats chronically processing in patients with
risk factors for schizophrenia: an treated with imipramine: effect of schizophrenia, 963
MRI study, 374 a,-adrenoceptor blockade, 766 Mao Z-M, Arnsten AFT, Li B-M. Local
Leschiner S. See Soreni N Linnoila M. See Lindell SG infusion of an a-1 adrenergic
Levitan C, Ward PB, Catts SV. Superior Little JT. See Kimbrell TA agonist into the prefrontal cortex
temporal gyral volumes and Liu H. See Giedd JN impaires spatial working memory
laterality correlates of auditory Locke J. See Hill SY performance in monkeys, 1259
hallucinations in schizophrenia, 955 Loddo P. See Di Chiara G Marazziti D, Presta S, Pfanner C,
Levy J. See Sunderland T Long JC. See Lappalainen J Gemignani A, Rossi A, Sbrana S,
Lewin JS. See Friedman L Longhurst JG, Carpenter LL, Epperson Rocchi V, Ambrogi F, Cassano GB.
Lewis DA, Pierri JN, Volk DW, CN, Price LH, McDougle CJ. Immunological alterations in adult
Melchitzky DS, Woo T-UW. Effects of catecholamine depletion obsessive-compulsive disorder, 810
Altered GABA neurotransmission with AMPT (alpha-methyl-para- Marmar CR. See Neylan TC
1724 BIOL PSYCHIATRY Author Index to Volume 46
1999:46:1718—1727
Marsh L. See Ford JM Miller DD. See Andreasen NC P50 suppression in combat
Marsh L. See Pearlson GD Miller HL. See Delgado PL veterans, 1656
Mathalon DH. See Ford JM Minderaa RB. See Althaus M Nichols S. See Brugge K
Mathis C. See Drevets WC Minor K, Park S. Spatial working Nicolson R. See Giedd JN
Matsumoto K. See Matsuoka H memory: absence of gender Nicolson R, Rapoport JL. Childhood-
Matsuoka H, Matsumoto K, Yamazaki differences in schizophrenia patients onset schizophrenia: rare but worth
H, Sakai H, Miwa S, Yoshida S, and healthy control subjects, 1003 studying, 1418
Numachi Y, Saito H, Ueno T, Sato Mintz J. See van Gorp WG Nierenberg AA, Burt T, Matthews J,
M. Lack of repetition priming Miwa S. See Matsuoka H Weiss AP. Mania associated with
effect on visual event-related Monaghan E. See Bowden CL St. John’s wort, 1707
potentials in schizophrenia, 137 Moore GJ. See Manji HK Nierenbery AA. See Alpert JE
Matthews J. See Nierenberg AA Moore H, West AR, Grace AA. The Niethammer R. See Weisbrod M
McCallin K. See Neylan TC regulation of forebrain dopamine Nomikos GG. See Linnér L
McConaha CW. See Gendall KA transmission: relevance to the Nopoulos PC. See Andreasen NC
McDougle CJ. See Longhurst JG pathophysiology and Nopoulos PC. See Corson PW
McEvoy JP, Freudenreich O, Wilson psychopathology of schizophrenia, Nopoulos PC, Ceilley JW, Gailis EA,
WH. Smoking and therapeutic 40 Andreasen NC. An MRI study of
response to clozapine in patients Moreno FA. See Delgado PL cerebellar vermis morphology in
with schizophrenia, 125 Moreno FA, Gelenberg AJ, Heninger GR, patients with schizophrenia:
McFarland H. See Roca CA Potter RL, McKnight KM, Allen J, evidence in support of the cognitive
McGaugh JL. See Ferry B Phillips AP, Delgado PL. dysmetria concept, 703
McGavin C. See Franklin M Tryptophan depletion and Noran A. See Underwood MD
McGlashan TH. Duration of untreated depressive vulnerability, 498 Numachi Y. See Matsuoka H
psychosis in first-episode Morgan CA III. See Southwick SM Nutt D. See Potokar J
schizophrenia: marker or Morgan K. See Stefanis N
determinant of course?, 899 Moss HB, Yao JK, Lynch K. Platelet O’Callaghan E. See Waddington JL
McKinney WT. See Clarke AS dense granule secretion and O’Connell P. See Stefanis N
McKnight KM. See Moreno FA aggregation in adolescents with Ofek H. See Apter A
Meaney MJ. See Francis DD conduct disorder: effects of O’Leary DS. See Andreasen NC
Meares RA. See Manor BR marijuana use, 790 Olincy A. See Adler LE
Meesters Y, Beersma DGM, Bouhuys Motter R. See Sunderland T Olincy A. See Ross RG
AL, van den Hoofdakker RH. Mrak RE. See Kyosseva SV Ordway GA. See Zhu M-Y
Prophylactic treatment of seasonal Mulder G. See Althaus M Orr SP. See Dougherty DD
affective disorder (SAD) by using Mulder LJM. See Althaus M Osuch E. See Kimbrell TA
light visors: bright white or infrared Murphy DL. See Tariot PN Overholser JC. See Zhu M-Y
light?, 239 Murray R. See Stefanis N Ozaki N. See Lappalainen J
Melchitzky DA. See Lewis DA Mustanoja S. See Haténen T
Meltzer HY. See Zhu M-Y Packing J. See Leonard CM
Meltzer HY. Dopamine, receptor Nakamura K. See Yamasa S Palkovits M. See Du L
occupancy and the action of Nelson J. See Giedd JN Palmatier MA. See Kang AM
clozapine: does it make a difference Nelson JC. A review of the efficacy of Palmatier MA, Kang AM, Kidd KK.
to add a neuroleptic?, 144-corr serotonergic and noradrenergic Global variation in the frequencies
Meltzer HY. Treatment of schizophrenia reuptake inhibitors for treatment of of functionally different catechol-O-
and spectrum disorders: major depression, 1301 methyltransferase alleles, 557
pharmacotherapy, psychosocial Nemeroff CB. See Charney DS Palmer BW. See Jeste DV
treatments, and neurotransmitter Nemeroff CB. See Heim C Pande AC, Greiner M, Adams JB,
interactions, 1321-ed Nemeroff CB. See Kinkead B Lydiard RB, Pierce MW. Placebo-
Menegazzo E. See Perini GI Nemeroff CB. See Ressler KJ controlled trial of the CCK-B
Merali Z. See Anisman H Nestler EJ. See Charney DS antagonist CI-988 in panic disorder,
Merikangas KR, Avenevoli S, Dierker L, Nestler EJ, Alreja M, Aghajanian GK. 860
Grillon C. Vulnerability factors Molecular control of locus Parekh PI. See Kimbrell TA
among children at risk for anxiety coeruleus neurotransmission, 1131 Park S. See Minor K
disorders, 1523 Neylan TC, Fletcher DJ, Lenoci M, Park S, Piischel J, Sauter BH, Rentsch M,
Meslin EM. The National Bioethics McCallin K, Weiss DS, Schoenfeld Hell D. Spatial working memory
Advisory Commission (NBAC) FB, Marmar CR, Fein G. Sensory deficits and clinical symptoms in
report, 1011 gating in chronic posttraumatic schizophrenia: a 4-month follow-up
Mikulis DJ. See Chow EWC stress disorder: reduced auditory study, 392
Author Index to Volume 46 BIOL PSYCHIATRY 1725
1999:46:1718—1727
Paulus MP, Perry W, Braff DL. The Pukhovsky A. See Silverstone PH fluid somatostatin, mood, and
nonlinear, complex sequential Piischel J. See Park S cognition in multiple sclerosis, 551
organization of behavior in Puyerovsky M. See Klein E Rocchi B. See Marazziti D
schizophrenic patients: Pynoos RS, Steinberg AM, Piacentini JC. Rodriguez Holguin S, Porjesz B, Chorlian
neurocognitive strategies and A developmental psychopathology DB, Polich J, Begleiter H. Visual
clinical correlations, 662 model of childhood traumatic stress P3a in male subjects at high risk
Pava JA. See Alpert JE and intersection with anxiety for alcoholism, 281
Pearlson GD, Marsh L. Structural brain disorders, 1542 Roessler E. See Hoffman RE
imaging in schizophrenia: a Rojas DC. See Reite M
selective review, 627 Quartermain D. See Stone EA Romano C. See Abderti A
Peoples J. See Van Bockstaele EJ Quintin P. See Leboyer M Roozendaal B. See Ferry B
Pérez V. See Figueras G Rosas Laurrabaquio M. See Salin-Pascual
Perini GI, Menegazzo E, Ermani M, Zara Radant A. See Ross RG RJ
M, Gemma A, Ferruzza E, Rajkowski J. See Aston-Jones G Rosenstein DL. IRB review of psychiatric
Gennarelli M, Angelini C. Rapoport JL. See Giedd JN medication discontinuation and
Cognitive impairment and (CTG)n Rapoport JL. See Nicolson R symptom-provoking studies, 1039
expansion in myotonic dystrophy Raskind MA, Peskind ER, Holmes C, Ross BM. See Hudson C
patients, 425 Goldstein DS. Patters of Ross RG. See Adler LE
Perry W. See Paulus MP cerebrospinal fluid catechols Ross RG, Olincy A, Harris JG, Radant A,
Perugini M. See Knott VJ support increased central Adler LE, Compagnon N,
Peskind ER. See Dukoff R noradrenergic responsiveness in Freedman R. The effects of age on
Peskind ER. See Raskind MA aging and Alzheimer’s disease, 756 a smooth pursuit tracking task in
Pfanner C. See Marazziti D Rasmusson A. See Southwick SM adults with schizophrenia and
Pfefferbaum A. See Ford JM Rauch SL. See Dougherty DD normal subjects, 383
Phillips AP. See Moreno FA Ravindran AV. See Anisman H Rossi A. See Marazziti D
Piacentini JC. See Pynoos RS Ravindran AV. See Knott VJ Rotzinger S. See Silverstone PH
Pichlbauer E. See Feucht M Reed A. See Franklin M Rubinow DR. See Roca CA
Pierce MW. See Pande AC Reite M, Teale P, Rojas DC, Sheeder J,
Pierri JN. See Lewis DA Arciniegas D. Schizoaffective Sachdev P, Saharov T, Cathcart S. The
Pine DS. Pathophysiology of childhood disorder: evidence for reversed preventative role of antioxidants
anxiety disorders, 1555 cerebral asymmetry, 133 (selegiline and vitamin E) in a rat
Pirrone P. See Abderti A Rennie CJ. See Manor BR model of tardive dyskinesia, 1672
Pitman RK. See Dougherty DD Rentsch M. See Park S Sackeim HA. See Light GA
Plotsky PM. See Francis DD Repella JD. See Kimbrell TA Sadiq S. See Printz DJ
Podell DM. See Kimbrell TA Ressler KJ, Nemeroff CB. Role of Saharov T. See Sachdev P
Polich J. See Rodriguez Holguin S norepinephrine in the Saito H. See Matsuoka H
Porjesz B. See Rodriguez Holguin S pathophysiology and treatment of Saitoh T. See Brugge K
Post RM. See Hough C mood disorders, 1219 Sakai H. See Matsuoka H
Post RM. See Ketter TA Reus VI. See Costa MM Salin-Pascual RJ, Herrera-Estrella M,
Post RM. See Kimbrell TA Rice PM. See Underwood MD Galicia-Polo L, Rosas Laurrabaquio
Potokar J, Wilson S, Nutt D, Lawson C. Richardson CM. See Conley RR M. Olanzapine acute administration
Behavioral, neuroendocrine, and Riddle MA. See Labellarte MJ in schizophrenic patients increases
cardiovascular response to Riedel WJ. See Klaasen T delta sleep and sleep efficiency,
flumazenil: no evidence for an Roberts B. See Roberts LW 14]
altered benzodiazepine receptor Roberts LW. Ethical dimensions of Salomon RM. See Delgado PL
sensitivity in panic disorder, psychiatric research: a constructive, San Martino O. See Figueras G
1709-corr criterion-based approach to protocol Sato M. See Matsuoka H
Potter RL. See Moreno FA preparation. The Research Protocol Sauer H. See Weisbrod M
Pouwels PJW. See Dechent P Ethics Assessment Tool (RePEAT), Sauter BH. See Park S
Presta S. See Marazziti D 1106 Sbrana S. See Marazziti D
Price JC. See Drevets WC Roberts LW, Roberts B. Psychiatric Scharfetter J. See Feucht M
Price LH. See Longhurst JG research ethics: an overview of Schmider J, Standhart H, Deuschle M,
Printz DJ. See Malaspina D evolving guidelines and current Drancoli J, Heuser I. A double-
Printz DJ, Strauss DH, Goetz R, Sadiq S, ethical dilemmas in the study of blind comparison of lorazepam and
Malaspina D, Krolewski J, Gorman mental illness, 1025 oxazepam in psychomotor
JM. Elevation of CD5+ B Roca CA, Su T-P, Elpern S, McFarland retardation and mutism, 437
lymphocytes in schizophrenia, 110 H, Rubinow DR. Cerebrospinal Schmidt DE. See Clarke AS
1726 BIOL PSYCHIATRY Author Index to Volume 46
1999:46:1718-—1727
Schoenfeld FB. See Neylan TC schizophrenia, 600 Wiedemann K. Behavioral,
Schork MA. See Starkman MN Sokolski KN. See DeMet EM neuroendocrine, and cardiovascular
Schteingart DE. See Starkman MN Soreni N, Apter A, Weizman A, Don- response to flumazenil: no evidence
Schulz SC. See Friedman L Tufeled O, Leschiner S, Karp L, for an altered benzodiazepine
Schulz SC, Camlin KL, Berry SA, Gavish M. Decreased platelet receptor sensitivity in panic
Jesberger JA. Olanzapine safety and peripheral-type benzodiazepine disorder, 1710-corr (response)
efficacy in patients with borderline receptors in adolescent inpatients Stuve TA. See Friedman L
personality disorder and comorbid with repeated suicide attempts, 484 Su T-P. See Roca CA
dysthymia, 1429 Sdétonyi P. See Du L Sullivan GM, Coplan JD, Kent JM,
Scutt LE. See Chow EWC Southwick SM, Bremner JD, Rasmusson Gorman JM. The noradrenergic
Seeman M. See Hudson C A, Morgan CA Ili, Arnsten A, system in pathological anxiety: a
Seidman LJ, Faraone SV, Goldstein JM, Charney DS. Role of focus on panic with relevance to
Goodman JM, Kremen WS, norepinephrine in the generalized anxiety and phobias,
Toomey R, Tourville J, Kennedy D, pathophysiology and treatment of 1205
Makris N, Caviness VS, Tsuang posttraumatic stress disorder, 1192 Sunderland T. See Dukoff R
MT. Thalamic and amygdala— Southwick SM, Morgan CA III, Charney Sunderland T. See Tariot PN
hippocampal volume reductions in DS, High JR. Yohimbine use in a Sunderland T, Wolozin B, Galasko D,
first-degree relatives of patients natural setting: effects on Levy J, Dukoff R, Bahro M, Lasser
with schizophrenia: an MRI-based posttraumatic stress disorder, 442 R, Motter R, Lehtimaki T, Seubert
morphometric analysis, 941 Speer AM. See Kimbrell TA P. Longitudinal stability of CSF tau
Selemon LD, Lidow MS, Goldman-Rakic Spencer T. See Biederman J levels in Alzheimer patients, 750
PS. Increased volume and glial Standhart H. See Schmider J Suomi SJ. See Lindell SG
density in primate prefrontal cortex Starkman MN, Giordani B, Gebarski SS, Svensson TH. See Linnér L
associated with chronic Berent S, Schork MA, Schteingart Swales TP. See Friedman L
antipsychotic drug exposure, 161 DE. Decrease in cortisol reverses Sweeney JA, Luna B, Haas GL,
Seubert P. See Sunderland T human hippocampal atrophy Keshavan MS, Mann JJ, Thase ME.
Shader RI. See von Moltke LL following treatment of Cushing’s Pursuit tracking impairments in
Sharma T. See Stefanis N disease, 1595 schizophrenia and mood disorders:
Sheeder J. See Reite M Steckler T, Holsboer F. Corticotropin- step-ramp studies with unmedicated
Shen S. See Hill SY releasing hormone receptor patients, 671
Shin LM. See Dougherty DD subtypes and emotion, 1480
Shirakawa O. See Lin X-H Stefanis N, Frangou S, Yakeley J, Tamminga CA. See Conley RR
Shoaf S. See Lindell SG Sharma T, O’Connell P, Morgan K, Tamminga CA. Neuroscience and
Shore D, Hyman SE. An NIMH Sigmudsson T, Taylor M, Murray schizophrenia, 301-ed
commentary on the NBAC report, R. Hippocampal volume reduction Tamminga CA, Lieberman JA.
1013 in schizophrenia: effects of genetic Schizophrenia research series: from
Shore D, Hyman SE. NIMH symptom risk and pregnancy and birth molecule to public policy, 3-ed
challenge and medication complications, 697 Tanaka M. See Yamasa S
discontinuation workshop, 1009-ed Steinberg AM. See Pynoos RS Tanapat P. See Gould E
Sieghart W. See Feucht M Steinhauer SR. See Hill SY Tanda G. See Di Chiara G
Sigmudsson T. See Stefanis N Stevens KE, Kem WR, Freedman R. Tariot PN, Upadhyaya A, Sunderland T,
Silverstone PH, Rotzinger S, Pukhovsky Selective a7 nicotinic receptor Cox C, Cohen RM, Murphy DL,
A, Hanstock CC. Effects of lithium stimulation normalized chronic Loy R. Physiologic and
and amphetamine on inositol cocaine-induced loss of neuroendocrine responses to
metabolism in the human brain as hippocampal sensory inhibition in intravenous naloxone in subjects
measured by 'H and *'P MRS, C3H mice, 1443 with Alzheimer’s disease and age-
1634 Stevenson MR. See Johnston TG matched controls, 412
Simpson PM. See Hamer RM Stiffler JS. See Zubenko GS Taylor JR. See Birnbaum S
Singer HS, Giuliano JD, Hansen BH, Stockmeier C. See Zhu M-Y Taylor M. See Stefanis N
Hallett JJ, Laurino JP, Benson M, Stone EA, Quartermain D. Alpha-1- Teale P. See Reite M
Kiessling LS. Antibodies against a noradrenergic neurotransmission, Tebartz van Elst L, Woermann FG,
neuron-like (HTB-10 neuroblastoma) corticosterone, and behavioral Lemieux L, Trimble MR.
cell in children with Tourette depression, 1287 Amygdala enlargement in
syndrome, 775 Storer S. See Malaspina D dysthymia—a volumetric study of
Snidman N. See Kagan J Strauss DH. See Printz DJ patients with temporal lobe
Soares JC, Innis RB. Neurochemical Stridsberg M. See Landén M epilepsy, 1614
brain imaging investigations of Stréhle A, Kellner M, Holsboer F, Terman JS, Terman M. Photopic and
Author Index to Volume 46 BIOL PSYCHIATRY 1727
1999:46:1718-1727
scotopic light detection in patients child and adolescent psychiatry Wilkinson CW. See Dukoff R
with seasonal affective disorder and research, 1044 Williams LM. See Manor BR
control subjects, 1642 Vogel-Scibilia SE. The controversy over Williams SA. See Leonard CM
Terman M. See Terman JS challenge and discontinuation Willis MW. See Ketter TA
Thase ME. See Sweeney JA studies: perspective from a Willis MW. See Kimbrell TA
Theberge DC. See van Gorp WG consumer-psychiatrist, 1021 Wilson S. See Potokar J
Thome J. See Duman RS Volavka J. See Carpenter WT Jr Wirz-Justice A, Van den Hoofdakker RH.
Tollefson GD, Andersen SW, Tran PV. Volk DW. See Lewis DA Sleep deprivation in depression:
The course of depressive symptoms von Moltke LL, Greenblatt DJ, Grassi what do we know, where do we
in predicting relapse in JM, Granda BW, Venkatakrishnan go?, 445
schizophrenia: a double-blind, K., Duan SX, Fogelman SM, Woermann FG. See van Elst LT
randomized comparison of Harmatz JS, Shader RI. Citalopram Wolkowitz OM. See Costa MM
olanzapine and risperidone, 365 and desmethylcitalopram in vitro: Wolozin B. See Sunderland T
Toomey R. See Seidman LJ human cytochromes mediating Woo T-UW. See Lewis DA
Tourville J. See Seidman LJ transformation, and cytochrome Worthington JJ Ill. See Alpert JE
Tran L. See Giedd JN inhibitory effects, 839 Wyatt RJ, Henter ID, Bartko JJ. The
Tran PV. See Tollefson GD long-term effects of placebo in
Trauner D. See Brugge K Waddington JL, Lane A, Larkin C, patients with chronic schizophrenia,
Trimble MR. See van Elst LT O’Callaghan E. The 1092
Trinder J. See Allen NB neurodevelopmental basis of
Tsuang MT. See Seidman LJ schizophrenia: clinical clues from Xu F. See Wang Y-M
cerebro-craniofacial
Uebelacker LA. See Alpert JE dysmorphogenesis, and the roots of Yakeley J. See Stefanis N
Ueno T. See Matsuoka H a lifetime trajectory of disease, 31 Yamada S, Harano M, Annoh N,
Underwood MD, Khaibulina AA, Ellis Waldo MC. See Adler LE Nakamura K, Tanaka M.
SP, Moran A, Rice PM, Mann JJ, Walkup JT. See Labellarte MJ Involvement of serotonin 2A
Arango V. Morphometry of the Wang Y-M, Xu F, Gainetdinov RR, receptors in phencyclidine-induced
dorsal raphe nucleus serotonergic Caron MG. Genetic approaches to disruption of prepulse inhibition of
neurons in suicide victims, 473 studying norepinephrine function: the acoustic startle in rats, 832
Upadhyaya A. See Tariot PN knockout of the mouse Yamazaki H. See Matsuoka H
norepinephrine transporter gene, Yao JK. See Moss HB
Vaituzis AC. See Giedd JN 1124 Yasuda N. See Izumoto Y
Valentino RJ. See Van Bockstaele EJ Ward PB. See Levitan C Yigit A. See Demirkol A
Van Bockstaele EJ, Peoples J, Valentino Warsh J. See Hudson C Yonkers KA. See Leibenluft E
RJ. Anatomic basis for differential Wassermann EM. See Kimbrell TA Yoshida S. See Matsuoka H
regulation of the rostrolateral peri— Wassink T. See Andreasen NC Young SN. See Knott VJ
locus coeruleus region by limbic Waters N. See Carlsson A
afferents, 1352 Wating RH. See Abderti A Zachrisson O. See Degl’ Innocenti A
Van den Hoofdakker RH. See Meesters Y Watson SJ. See Lopez JF Zara M. See Perini GI
Van den Hoofdakker RH. See Wirz- Weinberger DR. See Charney DS Zhu M-Y, Klimek V, Dilley GE,
Justice A. Weinberger DR. See Davis KL Haycock JW, Stockmeier C,
van der Gaag RJ. See Kemner C Weinberger DR. Schizophrenia: new Overhoiser JC, Meltzer HY,
van Engeland H. See Kemner C phenes and new genes, 3-ed Ordway GA. Elevated levels of
van Gorp WG, Altshuler L, Theberge Weisbrod M, Hill H, Niethammer R, tyrosine hydroxylase in the locus
DC, Mintz J. Declarative and Sauer H. Genetic influence on coeruleus in major depression, 1275
procedural memory in bipolar auditory information processing in Zipursky RB. See Chow EWC
disorder, 525 schizophrenia: P300 in monozygotic Zito JM. See Carpenter WT Jr
Van Heertum R. See Malaspina D twins, 721 Zubenko GS, Hughes HB, Stiffler JS.
van Praag HM. See Klaasen T Weiss AP. See Nierenberg AA Clinical and neurobiological
van Someren A. See Klaasen T Weiss DS. See Neylan TC correlates of DXS1047 genotype in
Varoquaux O. See Leboyer M. Weizman A. See Apter A Alzheimer’s disease, 173
Venkatakrishnan K. See von Moltke LL Weizman A. See Soreni N Zubenko GS, Hughes HB III, Stiffler JS.
Verbaten M. See Kemner C Weksberg R. See Chow EWC Clinical and neurobiological
Virkkunen M. See Lappalainen J West AR. See Moore H correlates of D10S1423 genotype in
Vitiello B, Jensen PS, Hoagwood K. Whale RWR. See Franklin M Alzheimer’s disease, 740
Integrating science and ethics in Wiedemann K. See Strdhle A Zuffante PA. See Leonard CM